SCHEMBL4603390

SCHEMBL4603390

CSc1nsc(-c2ccccc2F)n1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.42
MAPK1 P28482 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
DCUN1D1 Q96GG9 2/20 0.39
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.38
MPL P40238 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
MBNL1 Q9NR56 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
APEX1 P27695 1/20 0.35
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4607883 0.89 MAPK1 (0.38) TSHRMAPK1TDP1DCUN1D1ALDH1A1
SCHEMBL4605715 0.81 HSP90AA1 (0.49) TSHRMAPK1TDP1DCUN1D1ALDH1A1
SCHEMBL4605489 0.77 ADORA3 (0.53) TSHRMAPK1TDP1DCUN1D1ALDH1A1
SCHEMBL10550071 0.75 GAA (0.47) TSHRTDP1ALDH1A1KDM4ELMNA
SCHEMBL4607588 0.72 KDM4E (0.43) MAPK1TDP1KDM4EMEN1KMT2A
SCHEMBL4606363 0.71 PTGS2 (0.42) ALDH1A1KDM4ELMNAMPL
SCHEMBL4606077 0.70 ALDH1A1 (0.37) MAPK1TDP1DCUN1D1ALDH1A1KDM4E
SCHEMBL23405305 0.69 MAPK1 (0.41) MAPK1DCUN1D1ALDH1A1KDM4EMEN1
SCHEMBL5529380 0.69 HSP90AA1 (0.43) MAPK1TDP1DCUN1D1ALDH1A1KDM4E
SCHEMBL5532703 0.69 MAPK1 (0.49) MAPK1DCUN1D1ALDH1A1LMNAMBNL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1574505-B1 1,2,4-THIADIAZOLE COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2008-07-16 EP disclosed
US-7361675-B2 1,2,4-thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2008-04-22 US disclosed
US-20060167266-A1 1,2,4- thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-07-27 US disclosed
EP-1574505-A1 1,2,4-THIADIAZOLE COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2005-09-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167266-A1 1,2,4- thiadiazole compounds and use thereof CBR3, CBR1, NOX3 TSHR 95/4885MAPK1 1437/4885TDP1 2099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.